Difference between revisions of "Biobanking"
From SI410
| Line 6: | Line 6: | ||
==Technological Advances== | ==Technological Advances== | ||
| + | |||
===Virtual Biobanks=== | ===Virtual Biobanks=== | ||
| + | Virtual biobanks now allow access to samples without viewing the physical samples. Instead, an online request management system allows authorized requesters to obtain sample information remotely. The Clinical Translational and Science Awards (CTSA) Biobank Consortium aims to make an increasingly large virtual consortium biobank that can be used at multiple CSTA centers.<ref>Olson, Steve, and Adam, C. Berger. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Drug Development: Workshop Study. Washington D.C.: National Academies Press, 2011. eBook.</ref> | ||
===Genomic Sequencing=== | ===Genomic Sequencing=== | ||
| Line 15: | Line 17: | ||
==References== | ==References== | ||
| + | <references/> | ||
| + | |||
| + | [[category: Information Ethics]] | ||
| + | |||
| + | ([[Topics|back to index]]) | ||
Revision as of 02:18, 30 September 2012
Biobanks are large stores of human biological samples kept for research into genetic and environmental causes of disease. Biobanks allow for tissue or other genetic materials to be stored, anonymous from the donor.
Contents
Background
Technological Advances
Virtual Biobanks
Virtual biobanks now allow access to samples without viewing the physical samples. Instead, an online request management system allows authorized requesters to obtain sample information remotely. The Clinical Translational and Science Awards (CTSA) Biobank Consortium aims to make an increasingly large virtual consortium biobank that can be used at multiple CSTA centers.[1]
Genomic Sequencing
Ethical Implications
See Also
References
- ↑ Olson, Steve, and Adam, C. Berger. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Drug Development: Workshop Study. Washington D.C.: National Academies Press, 2011. eBook.
